The Role of Statins and Lipid-Lowering Drugs
Statins and other lipid-lowering drugs are essential components of the Acute Coronary Syndrome (ACS) Market. These medications are used to reduce cholesterol levels, which is a major risk factor for the development of atherosclerotic plaques in the coronary arteries. By stabilizing these plaques and reducing inflammation, statins play a crucial role in both the acute management and long-term prevention of ACS.
The market for statins is mature, but continuous innovation in this space is focused on developing more potent and well-tolerated drugs. The increasing emphasis on secondary prevention—preventing future cardiac events in patients who have already had an ACS—ensures a strong and sustained demand for these drugs. This vital role of lipid-lowering agents confirms their foundational importance in the Acute Coronary Syndrome Market.